Navigation Links
3-Drug Combo Improves Advanced Pancreatic Cancer Outcomes
Date:6/2/2008

Study finds treatment well-tolerated, kept tumors stable for almost 6 months

MONDAY, June 2 (HealthDay News) -- A combination therapy of gemcitabine, capecitabine and bevacizumab improves outcomes in patients with advanced pancreatic cancer, according to a multi-center study led by researchers at Roswell Park Cancer Institute in Buffalo, N.Y.

The study of 50 patients found that this combination treatment was well-tolerated by patients, was able to prevent tumors from progressing for almost six months, and improved median survival to 9.8 months.

The study was expected to be presented Monday at the American Society of Clinical Oncology annual meeting, in Chicago.

Patients with advanced pancreatic cancer -- one of the most deadly types of solid tumors -- have a median survival of six months after diagnosis. About 37,680 people in the United States will be diagnosed with pancreatic cancer in 2008.

While gemcitabine and capecitabine have improved quality of life for patients with advanced pancreatic cancer, they haven't led to a significant improvement in survival time, according to background information in the study.

Bevacizumab, which reduces blood supply to tumor, has improved outcomes when added to chemotherapy for patients with colon, lung and breast cancers.

More information

The National Cancer Institute has more about pancreatic cancer.



-- Robert Preidt



SOURCE: Roswell Park Cancer Institute, news release, June 2, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. 3-drug combination extremely promising as first-line therapy for multiple myeloma
2. Radiation and drug combo helps boost efficacy of lung cancer treatment
3. Aerobic, Weight Training Combo Best Against Diabetes
4. New antibiotic drug combo to speed up treatment of tuberculosis
5. Drug Combo Helps Fight Marfan Syndrome
6. Drug Combo Blocks Pain Without Impairing Movement
7. Two-Drug Combo Fights Brain Tumors
8. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
9. Drug Combo Boosts Multiple Myeloma Survival
10. Drug Combos Effective Against Rheumatoid Arthritis
11. Combo PET/CT Scan Helps Spot Breast Cancers Spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... February 13, 2016 , ... When an Au Pair comes all the way around ... are in for and they are often worried things won’t go well. More often than ... This year’s Au Pair of the Year winner’s all commented how their Au Pairs have ...
(Date:2/12/2016)... , ... February 12, 2016 , ... The law firm ... and Evangeline Parishes. The purpose of these scholarships is to encourage applicants to ... individuals to seek employment within these two parishes. , “We have available jobs ...
(Date:2/12/2016)... ... , ... Each year, the American Physical Therapy Association (APTA) offers a Combined ... Convention Center. Almost 10,000 physical therapists across the country are expected to attend this ... their chosen field and network with their colleagues. As in years past, HydroWorx ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... a Service (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into ... partners to offer real-time business intelligence (BI) to their small and medium business ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one ... consists of physicians establishing, leading and partnering with ambulatory surgery centers across the United ... Center, also known as an ASC, is a modern health care facility focused on ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... DIEGO and SEOUL, South ... Silicon Biosys­tems Menarini and Macrogen, Inc. today announced ... assays and innovative procedures for precision medicine in ... combine Silicon Biosystems, DEPArray™ digital-sorting technology with Macrogen,s ... of tests certified under the Clinical Laboratory Improvement ...
(Date:2/12/2016)... LOUISVILLE, Ky. , Feb. 12, 2016 ... it has completed a $47.1 million Series ... investors Cormorant Asset Management, Hillhouse Capital Group ... investors Morningside Venture Investments, AJU IB Investment, ... will be used to further advance clinical ...
(Date:2/11/2016)... Stem cells are primitive cells found in all multi-cellular ... to differentiate into mature cell types Stem cells are ... embryonic stem cells were derived from embryos in 1981, ... culturing of embryonic stem cells from non-human primates occurred ... As a result of these discoveries, stem cells can ...
Breaking Medicine Technology: